[A contribution on diagnostic and therapy of myxoedema coma (author's transl)].
With special reference to diagnostic and therapeutic problems, a case of myxoedema coma with secondary hyperaldosteronism and raised LDH-concentration is described. The significance of different states of consciousness due to this endocrine disorder is pointed out with respect to the differential diagnosis and particularly to the clinical symptoms. In addition, experience with an intravenously administrable triiodothyronine compound is described and the different dosages previously mentioned in the leterature are discussed. The long interval of 5 weeks from the beginning of the therapy until the remission of the omatous state was surprising.
D000368:Aged; D003128:Coma / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000150:complications; D009230:Myxedema / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D012075:Remission, Spontaneous; D013148:Spironolactone / Q000627:therapeutic use; D014284:Triiodothyronine / Q000627:therapeutic use
D014284:Triiodothyronine; D013148:Spironolactone
Ein Beitrag zur Diagnostik und Therapie des Myxödemkomas